InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Wallace Max N., 董事. Officer active across 1 company, notably Humacyte, Inc.. In total, 3 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €23k. History available since 21 November 2023. The latest transaction was filed on 20 May 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Wallace Max N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
4,015 股@ US$6.2176.3% 占其流量Common StockSEC:0001818382-24-000067:0
标准退出：2024年8月18日 (T+90)
6,564 股@ US$1.1923.7% 占其流量Common StockSEC:0001818382-23-000165:0
49,986 股Common StockSEC:0001104659-21-110531:0
3 条申报中的 3 条
About Wallace Max N.
Max N. Wallace is a Board Member at Humacyte, Inc. As a board member, he participates in the governance and oversight of the company's activities. His experience in the biotechnology sector is an asset to the board.
